AliveCor, Inc. v. Apple, Inc., No. 23-1512 (Fed. Cir. 2025) – On March 7, 2025, the Federal Circuit affirmed the Patent Trial and Appeal Board’s inter partes review (“IPR”) decisions invalidating all ...
On March 7, 2025, the Federal Circuit issued a decision resolving the ongoing patent litigation between AliveCor and Apple concerning methods of cardiac monitoring purportedly employed in certain of ...
San Francisco-based AliveCor announced that the FDA has granted its smartphone-enabled, single-channel ECG (electrocardiogram) recorder device over-the-counter (OTC) clearance. The company is now ...
Apple and health technology company AliveCor have been embroiled in multiple legal battles for years, including a back-and-forth case with the International Trade Commission. In a decision today, the ...
11monon MSN
Apple wins patent battle against AliveCor
A federal court has ruled in Apple's favor in the years-long fight against AliveCor, preventing a potential total import ban on the Apple Watch.
Mobile health technology company AliveCor and remote monitoring company Preventice Solutions are piloting a mobile technology to analyze echocardiograms more efficiently. Preventice Solutions, a ...
This morning, San Francisco-based AliveCor rebranded its AliveCor Mobile ECG device as Kardia Mobile and unveiled a second, upcoming hardware product, an Apple Watch strap that can take ...
MOUNTAIN VIEW, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results